“…A recent JIBS Perspective urged international business scholars to research the link between grand challenges and international business via an interdisciplinary approach (Buckley, Doh, & Benischke, 2017). Yet, despite a potential link between international business activities and communicable diseases, we rarely observe international business studies addressing this particular relationship, other than studies examining occupational health and safety (Arnold & Bowie, 2003Collings, Scullion, & Morley, 2007;Himmelberger & Brown, 1995) or other issues where health directly affects the financial bottom line, including accessibility to medicines and healthcare services in the global pharmaceutical industry (Flanagan & Whiteman, 2007;Ghauri & Rao, 2009;Leisinger, 2005Leisinger, , 2009, multinationals' activities designed to enhance local community health in poor host countries (Gifford & Kestler, 2008;Gold, Hahn, & Seuring, 2013;Van Cranenburgh & Arenas, 2014), the role of food and tobacco multinationals in addressing noncommunicable diseases (Gertner & Rifkin, 2018;Mukherjee & Ekanayake, 2009;Palazzo & Richter, 2005;Tempels, Blok, & Verweij, 2020), and product safety assurance in global value chains (Bapuji & Beamish, 2019;Scruggs & Van Buren, 2016). Coincidentally, public health researchers have already engaged in these conversations, mostly questioning multinationals' role in global health from a critical perspective (Baum, Sanders, Fisher, Anaf, Freudenberg, & Friel, 2016;Baum & Anaf, 2015;Freudenberg, 2014;Kadandale, Marten, & Smith, 2019;Kickbusch, Allen, & Franz, 2016;Moodie, Stuckler, Monteiro, Sheron, Neal, & Thamarangsi, 2013;Mu ¨ller et al, 2021;Stuckler, McKee, Ebrahim, & Basu, 2012).…”